New Marijuana-Based Epilepsy Treatment to Cost $32,500 a Year!

Image result for marijuana epilepsy

If it is covered by private insurance or Medicaid that will be a great improvement for qualifying patients, but otherwise GW Pharma’s newly approved CBD drug Epidiolex will cost sick patients over $32,500 a year.

That is roughly 10 times what the average medical patient spends on medical cannabis in robust state markets.

As new cannabis based pharmaceuticals come on to the market, patients will compare not only effectiveness and safety, price will also be an important factor. For those patients without insurance that covers the high costs of new prescription cannabis pharmaceuticals, it is likely that purchasing from a state medical cannabis program will still be the most effective way to get relief.


“The news that makes this analysis possible comes from Marijuana Moment’s Daily Newsletter. Make sure to support the high-quality reporting that keeps us all informed!”

cannabist economist
Cannabist economist

Cananbis economist, andrew livingston, vicente sederberg

Leave a Reply

Your email address will not be published. Required fields are marked *